ALNY vs LUMN · P/E 76, rev $1.29B vs rev $5.70B
Alnylam Pharmaceuticals Inc (ALNY) versus Lumen Technologies Inc (LUMN) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Lumen Technologies Inc (LUMN) is a telecom services company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported LUMN revenue for 2026-06-30 was $5.70B. Net income was -$401.0M. Revenue was up 96.8% from 2026-03-31 to 2026-06-30. LUMN currently screens at market cap $4.72B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. LUMN currently screens at market cap $4.72B.
Not investment advice. Open the ALNY and LUMN stock pages for the full models.
Not investment advice.